Discontinuation report TEVA-PROGESTERONE
| Report ID | 258574 |
| Drug Identification Number | 02439913 |
| Brand name | TEVA-PROGESTERONE |
| Common or Proper name | PROGESTERONE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | PROGESTERONE |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | G03DA |
| ATC description | PROGESTOGENS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | Reversed |
| Discontinuation decision reversal | Yes |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-06-20 | French | Compare |
| v3 | 2025-06-20 | English | Compare |
| v2 | 2025-05-28 | French | Compare |
| v1 | 2025-05-28 | English | Compare |
Showing 1 to 4 of 4